Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes

A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Lindemann, L., Jaeschke, G., Michalon, A., Vieira, E., Honer, M., Spooren, W., Porter, R., Hartung, T., Kolczewski, S., Büttelmann, B., et al. (1909) · JAMA · doi:10.1001/jama.1909.02550020033007 · Cited by 7,865 · see citing works

Untitled work

(2000) · PubMed · Cited by 684 · see citing works

N-acetylation pharmacogenetics.

Weber, W. W., & Hein, D. W. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06816-4 · Cited by 650 · see citing works

Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis

Hein, D. W. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00153-7 · Cited by 518 · see citing works

Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases

Hein, D. W., Doll, M. A., Rustan, T. D., Gray, K. A., Feng, Y., Ferguson, R. J., & Grant, D. M. (1993) · Carcinogenesis · doi:10.1093/carcin/14.8.1633 · Cited by 359 · see citing works

Molecular mechanism of slow acetylation of drugs and carcinogens in humans.

Blum, M., Demierre, A., Grant, D. M., Heim, M. H., & Meyer, U. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5237 · Cited by 343 · see citing works

Acetylator genotype and arylamine-induced carcinogenesis

Hein, D. W. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90004-2 · Cited by 321 · see citing works

HUMAN ACETYLATION POLYMORPHISM.

Evans, D. A. P., & WHITE, T. A. (1964) · PubMed · Cited by 302 · see citing works

Trimodality of Isoniazid Elimination: Phenotype and Genotype in Patients With Tuberculosis

Parkin, D. P., Vandenplas, S., Botha, F. J., Vandenplas, M. L., Seifart, H. I., van Helden, P. D., van der Walt, B. J., Donald, P. R., & Jaarsveld, P. P. V. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.5.9154882 · Cited by 190 · see citing works

Structure of arylamine N-acetyltransferase reveals a catalytic triad

Noble, M. E. M., Sinclair, J. C., Sandy, J., Delgoda, R., & Sim, E. (2000) · Nature Structural Biology · doi:10.1038/76783 · Cited by 186 · see citing works

Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver.

Deguchi, T., Mashimo, M., & Suzuki, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38219-5 · Cited by 180 · see citing works

Expression of arylamine N -acetyltransferase in human intestine

Hickman, D., Pope, J., Patil, S. D., Fakis, G., Smelt, V., Stanley, L. A., Payton, M. A., Unadkat, J. D., & Sim, E. (1998) · Gut · doi:10.1136/gut.42.3.402 · Cited by 147 · see citing works

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2

McDonagh, E. M., Boukouvala, S., Aklillu, E., Hein, D. W., Altman, R. B., & Klein, T. E. (2014) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000062 · Cited by 146 · see citing works

N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine

Hein, D. W. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902877698 · Cited by 133 · see citing works

Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.

Grant, D. M., Mörike, K., Eichelbaum, M. F., & Meyer, U. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114527 · Cited by 126 · see citing works

Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.

Adam, P. J., Berry, J. M., Loader, J., Tyson, K. L., Craggs, G., Smith, P. D., de Belin, J., Steers, G., Pezzella, F., Sachsenmeir, K. F., et al. (2003) · PubMed · Cited by 114 · see citing works

Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2

Zang, Y., Doll, M. A., Zhao, S., States, J. C., & Hein, D. W. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm085 · Cited by 111 · see citing works

Identification of N-Acetyltransferase 2 (NAT2) Transcription Start Sites and Quantitation of NAT2-Specific mRNA in Human Tissues

Husain, A., Zhang, X., Doll, M. A., States, J. C., Barker, D. F., & Hein, D. W. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.014621 · Cited by 90 · see citing works

Proteasomal Degradation of N-Acetyltransferase 1 Is Prevented by Acetylation of the Active Site Cysteine

Butcher, N. J., Arulpragasam, A., & Minchin, R. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312858200 · Cited by 80 · see citing works

Immunochemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder.

Stanley, L. A., Coroneos, E., Cuff, R., Hickman, D., Ward, A. J., & Sim, E. (1996) · Journal of Histochemistry & Cytochemistry · doi:10.1177/44.9.8773572 · Cited by 79 · see citing works

Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke

Faraglia, B. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg013 · Cited by 76 · see citing works

Comprehensive Human NAT2 Genotype Method Using Single Nucleotide Polymorphism-Specific Polymerase Chain Reaction Primers and Fluorogenic Probes

Doll, M. A., & Hein, D. W. (2001) · Analytical Biochemistry · doi:10.1006/abio.2000.4892 · Cited by 61 · see citing works

The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation

Zang, Y., Zhao, S., Doll, M. A., States, J. C., & Hein, D. W. (2004) · Pharmacogenetics · doi:10.1097/00008571-200411000-00002 · Cited by 60 · see citing works

Caffeine Acetylator Phenotyping during Maturation in Infants

Pariente‐Khayat, A., Pons, G., Rey, E., Richard, M., d’Athis, P., Moran, C., Badoual, J., & Olivé, G. (1991) · Pediatric Research · doi:10.1203/00006450-199105010-00015 · Cited by 58 · see citing works

Prostate-Specific Human N-Acetyltransferase 2 (NAT2) Expression in the Mouse

Leff, M. A., Epstein, P. N., Doll, M. A., Fretland, A. J., Devanaboyina, U., Rustan, T. D., & Hein, D. W. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34882-7 · Cited by 54 · see citing works

N-Acetyltransferases, sulfotransferases and heterocyclic amine activation in the breast

Williams, J. A., Stone, E. M., Fakis, G., Johnson, N., Cordell, J., Meinl, W., Glatt, H. R., Sim, E., & Phillips, D. H. (2001) · Pharmacogenetics · doi:10.1097/00008571-200107000-00002 · Cited by 54 · see citing works

Tissue distribution of N ‐acetyltransferase 1 and 2 catalyzing the N ‐acetylation of 4‐aminobiphenyl and O ‐acetylation of N ‐hydroxy‐4‐aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster

Hein, D. W., Doll, M. A., Nerland, D. E., & Fretland, A. J. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20164 · Cited by 54 · see citing works

Role of human sulfotransferase 1A1 and N-acetyltransferase 2 in the metabolic activation of 16 heterocyclic amines and related heterocyclics to genotoxicants in recombinant V79 cells

Chevereau, M., Glatt, H. R., Zalko, D., Cravedi, J., & Audebert, M. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1935-8 · Cited by 54 · see citing works

Functional Analysis of the Human N-Acetyltransferase 1 Major Promoter: Quantitation of Tissue Expression and Identification of Critical Sequence Elements

Husain, A., Zhang, X., Doll, M. A., States, J. C., Barker, D. F., & Hein, D. W. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016485 · Cited by 52 · see citing works

Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1

Barker, D. F., Husain, A., Neale, J. R., Martini, B. D., Zhang, X., Doll, M. A., States, J. C., & Hein, D. W. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000215066.29342.26 · Cited by 51 · see citing works

2‐amino‐1‐methyl‐6‐phenylimidazo [4,5‐b] pyridine‐induced DNA adducts and genotoxicity in chinese hamster ovary (CHO) cells expressing human CYP1A2 and rapid or slow acetylator N‐acetyltransferase 2

Metry, K. J., Zhao, S., Neale, J. R., Doll, M. A., States, J. C., McGregor, W. G., Pierce, W. M. J., & Hein, D. W. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20302 · Cited by 48 · see citing works

Localization of polymorphic N-acetyltransferase (NAT2) in tissues of inbred mice

Stanley, L. A., Mills, I. G., & Sim, E. (1997) · Pharmacogenetics · doi:10.1097/00008571-199704000-00005 · Cited by 43 · see citing works

Codominant Expression of N-Acetylation and O-Acetylation Activities Catalyzed by N-Acetyltransferase 2 in Human Hepatocytes

Doll, M. A., Zang, Y., Moeller, T. A., & Hein, D. W. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168567 · Cited by 41 · see citing works

Arylamine N-acetyltransferase from chicken liver. I. Monoclonal antibodies, immunoaffinity purification, and amino acid sequences.

Deguchi, T., Sakamoto, Y., Sasaki, Y., & Uyemura, K. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68530-8 · Cited by 38 · see citing works

Identification and functional characterization of novel polymorphisms associated with the genes for arylamine N-acetyltransferases in mice

Boukouvala, S., Price, N., & Sim, E. (2002) · Pharmacogenetics · doi:10.1097/00008571-200207000-00006 · Cited by 37 · see citing works

Kinetic discrimination of three sulfamethazine acetylation phenotypes

Chapron, D. J., Kramer, P. A., & Mercik, S. A. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.16 · Cited by 36 · see citing works

Differences between human slow N-acetyltransferase 2 alleles in levels of 4-aminobiphenyl-induced DNA adducts and mutations

Bendaly, J., Doll, M. A., Millner, L., Metry, K. J., Smith, N. B., Pierce, W. M. J., & Hein, D. W. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.08.003 · Cited by 34 · see citing works

Antibodies recognizing the C terminus of PP2A catalytic subunit are unsuitable for evaluating PP2A activity and holoenzyme composition

Frohner, I. E., Mudrak, I., Kronlachner, S., Schüchner, S., & Ogris, E. (2020) · Science Signaling · doi:10.1126/scisignal.aax6490 · Cited by 34 · see citing works

The influence of various genotypes on the metabolic activity of NAT2 in a Chinese population

Chen, B. Y., Zhang, W., & Cai, W. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0110-6 · Cited by 32 · see citing works

Construction of Syrian Hamster Lines Congenic at the Polymorphic Acetyltransferase Locus (NAT2): Acetylator Genotype-Dependent N- and O-Acetylation of Arylamine Carcinogens

Hein, D. W., Doll, M. A., Rustan, T. D., Gray, K., Ferguson, R. J., & Feng, Y. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1003 · Cited by 30 · see citing works

Xenobiotic inducible regions of the human arylamine N-acetyltransferase 1 and 2 genes

Mitchell, K. R., & Warshawsky, D. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(02)00437-x · Cited by 29 · see citing works

Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.

Hein, D. W., Trinidad, A. C., Yerokun, T., Ferguson, R. J., Kirlin, W. G., & Weber, W. W. (1988) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06943-0 · Cited by 28 · see citing works

The Myc tag monoclonal antibody 9E10 displays highly variable epitope recognition dependent on neighboring sequence context

Schüchner, S., Behm, C., Mudrak, I., & Ogris, E. (2020) · Science Signaling · doi:10.1126/scisignal.aax9730 · Cited by 28 · see citing works

Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes

Doll, M. A., & Hein, D. W. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1988-8 · Cited by 24 · see citing works

N-Acetyltransferase 1 Knockout Elevates Acetyl Coenzyme A Levels and Reduces Anchorage-Independent Growth in Human Breast Cancer Cell Lines

Stepp, M. W., Salazar‐González, R. A., Hong, K. U., Doll, M. A., & Hein, D. W. (2019) · Journal of Oncology · doi:10.1155/2019/3860426 · Cited by 24 · see citing works

Polymorphic and monomorphic expression of arylamine carcinogen N-acetyltransferase isozymes in tumor target organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus.

Hein, D. W., Rustan, T. D., Bucher, K. D., & Miller, L. S. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20512-2 · Cited by 23 · see citing works

NATb/NAT1*4 promotes greater arylamine N‐acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4‐aminobiphenyl

Millner, L., Doll, M. A., Cai, J., States, J. C., & Hein, D. W. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20836 · Cited by 20 · see citing works

Expression and genotype-dependent catalytic activity of N-acetyltransferase 2 (NAT2) in human peripheral blood mononuclear cells and its modulation by Sirtuin 1

Salazar-González, R. A., Turiján-Espinoza, E., Hein, D. W., Milán-Segovia, R. C., Uresti-Rivera, E. E., & Portales-Pérez, D. P. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.034 · Cited by 20 · see citing works

Quantitative Tissue and Gene-Specific Differences and Developmental Changes in Nat1, Nat2, and Nat3 mRNA Expression in the Rat

Barker, D. F., Walraven, J. M., Ristagno, E. H., Doll, M. A., States, J. C., & Hein, D. W. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023564 · Cited by 19 · see citing works

Role of Human N‐Acetyltransferase 2 Genetic Polymorphism on Aromatic Amine Carcinogen‐Induced DNA Damage and Mutagenicity in a Chinese Hamster Ovary Cell Mutation Assay

Baldauf, K. J., Salazar‐González, R. A., Doll, M. A., Pierce, W. M. J., States, J. C., & Hein, D. W. (2019) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22331 · Cited by 17 · see citing works

Systemic Functional Expression of N-Acetyltransferase Polymorphism in the F344 Nat2 Congenic Rat

Hein, D. W., Bendaly, J., Neale, J. R., & Doll, M. A. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023960 · Cited by 15 · see citing works

Effects of NAT2 polymorphism on SASP pharmacokinetics in Chinese population

Ma, J., Liu, C.-G., Li, J.-H., Cao, X., Sun, S.-L., & Yao, X. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.06.025 · Cited by 13 · see citing works

Functional Genomics of C190T Single Nucleotide Polymorphism in Human N-Acetyltransferase 2

Zhu, Y., Doll, M. A., & Hein, D. W. (2002) · Biological Chemistry · doi:10.1515/bc.2002.105 · Cited by 12 · see citing works

Arylamine N-acetyltransferases In Health And Disease: From Pharmacogenetics To Drug Discovery And Diagnostics

Laurieri, N., & Sim, E. (2018) · WORLD SCIENTIFIC eBooks · doi:10.1142/10763 · Cited by 10 · see citing works

Human Arylamine N-Acetyltransferase Type 2: Phenotypic Correlation with Genotype-A Clinical Perspective

Agúndez, J. A. G., & García‐Martín, E. (2018) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789813232013_0003 · Cited by 6 · see citing works

Arylamine N-Acetyltransferases in Normal and Abnormal Embryonic Development

Stanley, L. A., & Sim, E. (2018) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789813232013_0005 · Cited by 2 · see citing works

Differences in β-naphthylamine metabolism and toxicity in Chinese hamster ovary cell lines transfected with human CYP1A2 and NAT2*4, NAT2*5B or NAT2*7B N-acetyltransferase 2 haplotypes

Habil, M. R., Salazar‐González, R. A., Doll, M. A., & Hein, D. W. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03367-2 · Cited by 18 · see citing works

Transcriptional Regulation of Human Arylamine N-Acetyltransferase 2 Gene by Glucose and Insulin in Liver Cancer Cell Lines

Hong, K. U., Salazar‐González, R. A., Walls, K. M., & Hein, D. W. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac103 · Cited by 11 · see citing works

Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis

Thomas, L., Raju, A. P., Mallayasamy, S., & Rao, M. (2024) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-024-00910-7 · Cited by 10 · see citing works

Arylamine N-acetyltransferase 1 activity is regulated by the protein acetylation status

Salazar-González, R. A., Doll, M. A., & Hein, D. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.797469 · Cited by 9 · see citing works

Non-coding and intergenic genetic variants of human arylamine N-acetyltransferase 2 (NAT2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders

Hong, K. U., Walls, K. M., & Hein, D. W. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1091976 · Cited by 9 · see citing works

Human N-Acetyltransferase 1 and 2 Differ in Affinity Towards Acetyl-Coenzyme A Cofactor and N-Hydroxy-Arylamine Carcinogens

Hein, D. W., Doll, M. A., & Habil, M. R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.821133 · Cited by 8 · see citing works

The rs1801280 SNP is associated with non-small cell lung carcinoma by exhibiting a highly deleterious effect on N-acetyltransferase 2

Lawi, Z. K. K., Al‐Shuhaib, M. B. S., & Amara, I. B. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04332-3 · Cited by 6 · see citing works

Hexavalent chromium increases the metabolism and genotoxicity of aromatic amine carcinogens 4-aminobiphenyl and β-naphthylamine in immortalized human lung epithelial cells

Wise, J. T. F., Salazar‐González, R. A., Walls, K. M., Doll, M. A., Habil, M. R., & Hein, D. W. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116095 · Cited by 6 · see citing works

Effect of Food Composition on the PK of Isoniazid Quantitatively Explained Using Physiologically Based Biopharmaceutics Modeling

Pepin, X. J. H., & Suarez‐Sharp, S. (2024) · The AAPS Journal · doi:10.1208/s12248-024-00923-9 · Cited by 4 · see citing works

Association of NAT2 promoter hypermethylation with susceptibility to hepatotoxicity due to antituberculosis drugs and biomarker potential

Jittikoon, J., Saengsiwaritt, W., Chanhom, N., Chaikledkaew, U., Wattanapokayakit, S., Mahasirimongkol, S., & Udomsinprasert, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-95050-6 · Cited by 4 · see citing works

The expression pattern of N‐acetyltransferase 1 in healthy human skin

van Amerongen, C. C. A., Kramer, D., Pas, H. H., & Schuttelaar, M. L. A. (2021) · Contact Dermatitis · doi:10.1111/cod.13821 · Cited by 3 · see citing works

Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells

Wise, J. T. F., Salazar‐González, R. A., Habil, M. R., Doll, M. A., & Hein, D. W. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.115993 · Cited by 3 · see citing works

Systematic review on genetic polymorphisms associated with idiosyncratic drug-induced liver injury (iDILI): iDILInet as an interactive visualization tool

Matilla‐Cabello, G., Remesal-Doblado, Á., Çelebi-Çınar, M., Bodoque-García, A., Metin, F. B., Rezaei, A., Aftab, A. M., Santos‐Fernández, R. L. D. L., Segovia‐Zafra, A., Álvarez‐Álvarez, I., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.03.030 · Cited by 2 · see citing works

Metabolism and genotoxicity of 4,4’-oxydianiline is dependent on N-acetyltransferase 2 genetic polymorphism

Salazar‐González, R. A., Wise, J. T. F., Doll, M. A., & Hein, D. W. (2025) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2025.104699 · Cited by 2 · see citing works

N-Acetyltransferase (NAT) 1 and NAT2 Enzyme Activities Drive Interindividual Variability in Sulfamethoxazole N-Acetylation

Lanphier, R. M., Latham, B. D., Gerringer, A. J., Interrante, T., Jones, C. D., De Buysscher, T., Fallon, J. K., & Jackson, K. D. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100195 · Cited by 1 · see citing works

Arylamine N-Acetyltransferases

Boukouvala, S., Fakis, G., Stavrakaki, I., Polycarpou, E., Laurieri, N., & Sim, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00020-6 · Cited by 1 · see citing works

Investigation of human n-acetyltransferases (NAT1 and NAT2) genetic polymorphisms in susceptibility to aromatic amine and alkylaniline genotoxicity.

Habil, M. R. (2022) · doi:10.18297/etd/4007 · Cited by 1 · see citing works

Contact Allergy: Occurrence and Susceptibility

van Amerongen, C. C. A. (2021) · doi:10.33612/diss.180838927

Effects of Genetic Polymorphism on Xenobiotic-Induced Genetic Damage and Diseases

Saini, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-28619-2_9

Aromatic amine exposure and bladder cancer: a review of recent advances in epidemiology, pathogenesis, and prevention

Li, S., Zhang, Y., Mao, T., Wei, J., Zhang, W., Zhang, J., & Wei, W. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1914792

Understanding the High Pharmacokinetic Variability of 5-Aminosalicylic Acid Drug Products Using Compartmental, Semi-mechanistic, and Mechanistic Pharmacokinetic Models

Kunjir, S. A., Dhyagala, S., Rohila, A., Kumar, A., Sirvi, P. K., & Malayandi, R. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03581-6

Codominant Expression of N-Acetylation and O-Acetylation Activities Catalyzed by N-Acetyltransferase 2 in Human Hepatocytes

Doll, M. A., Zang, Y., Moeller, T. A., & Hein, D. W. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168567 · Cited by 41 · see citing works

N-Acetyltranserase 2 (NAT2) genotype polymorphism in cryopreserved human hepatocytes and Chinese hamster ovary (CHO) cells.

Habil, M. R. (2020) · doi:10.18297/etd/3487

Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes

Doll, M. A., Salazar‐González, R. A., Bodduluri, S., & Hein, D. W. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.05.003 · Cited by 20 · see citing works

Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes

Doll, M. A., & Hein, D. W. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1988-8 · Cited by 24 · see citing works

Human Arylamine N -Acetyltransferase Genes: Isolation, Chromosomal Localization, and Functional Expression

BLUM, M., Grant, D. M., McBride, W. O., Heim, M. H., & Meyer, U. (1990) · DNA and Cell Biology · doi:10.1089/dna.1990.9.193 · Cited by 435 · see citing works